Results 161 to 170 of about 11,493 (199)

Modelling anti-Ov16 Seroprevalence for the Control and Elimination of Onchocerciasis

open access: yes
Basáñez M   +6 more
europepmc   +1 more source

ONCHOCERCIASIS

Infectious Disease Clinics of North America, 1992
Onchocerciasis is a parasitic disease with blinding consequences infecting approximately 18 million persons worldwide. In hyperendemic areas, nearly half the population are likely to become blind before they die. Blindness reduces the life expectancy of those affected and has an enormous socioeconomic impact on these communities. Ivermectin, given as a
A E, Malatt, H R, Taylor
openaire   +2 more sources

Onchocerciasis

International Ophthalmology, 1990
Onchocerciasis is a devastating blinding disease caused by the parasite Onchocerca volvulus that infects about 80 million people, causing blindness and visual impairment in 1-2 million people. In hyperendemic areas, more than half of the population will become blind from onchocerciasis before they die.
openaire   +4 more sources

Cutaneous Onchocerciasis

International Journal of Dermatology, 1987
ABSTRACT: Onchocerciasis was diagnosed when a skin biopsy specimen immersed in saline revealed microfiliariae. The patient was a 22‐year‐old student from Cameroon, West Africa, complaining of small, recurrent, pruritic papules on his thighs. Chemotherapy with ivermectin, an established anti‐parasitic agent with newly recognized anti‐onchocercal ...
M J, Maso   +5 more
openaire   +2 more sources

Treatment of Onchocerciasis

Drugs, 1996
Onchocerciasis ('river blindness') has for several centuries been the scourge of people living in certain areas of the world where the disease is endemic. The treatment available up to 10 years ago, diethylcarbamazine, had very severe secondary effects.
Y, Van Laethem, C, Lopes
openaire   +2 more sources

Home - About - Disclaimer - Privacy